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Background  and  purpose      Venous  thromboembolism  (VTE) 
remains a substantial cause of morbidity and mortality follow-
ing hip fracture. Previous work has not identified any risk factors 
associated with the type of hip fracture. We report the incidence of 
and risk factors for development of symptomatic VTE in patients 
following a hip fracture. 
Patients and methods   In this prospective study, we collected 
information on 5,300 consecutive patients who were admitted to 
a single unit with a hip fracture—in terms of their pre-admission 
status, details of any operation performed, and details of compli-
cations in the form of symptomatic venous thromboembolism. All 
patients received thromboprophylaxis with heparin. 
Results   The incidence of symptomatic VTE was 2.2% (95% 
CI: 1.8–2.6). 85% of these events occurred within 5 weeks of the 
fracture. The statistically significant risk factors for symptomatic 
VTE were better preoperative mobility, living in one’s own home, 
high mental test score, high preoperative hemoglobin, inter-tro-
chanteric fractures, and fixation with a dynamic hip screw. In 
multivariate analysis adjusting for sex and age, type of residence 
on admission, type of fracture, and hemoglobin values on admis-
sion remained independently significant. 
Interpretation   We found that the rate of symptomatic VTE 
using thromboprophylaxis with heparin was low but that there 
were a number of groups that were at a significantly higher risk of 
developing VTE. The patients who are particularly at risk appear 
to be those with a subtrochanteric or intertrochanteric hip frac-
ture; here, the incidence of symptomatic VTE was twice that of 
intracapsular hip fractures.

Venous thrombosis is a substantial cause of morbidity and 
mortality in patients following hip fracture (Todd et al. 1995). 
Asymptomatic deep vein thrombosis (DVT) has been reported 
in up to 50% of all patients who sustain a hip fracture, with 
an incidence of fatal pulmonary embolus (PE) of up to 10% 
(Haake and Berkman 1989, Todd et al. 1995, Zahn et al. 1999). 
The incidence of asymptomatic thrombi will always be mark-
edly higher than those that are clinically apparent. 
The purpose of this study was to determine the incidence of 
symptomatic VTE in patients following hip fracture, from a 
single centre, to ascertain any pre-existing admission charac-
teristics that might increase the risk, to examine the surgical 
risk factors, and to determine the time period over which the 
symptomatic VTE was diagnosed.
Patients and methods
The details of all patients with a proximal femoral fracture 
presenting at a single institution (Peterborough District Hos-
pital, U.K.) between January 1989 and January 2007 were 
recorded at the time of admission. The collection of data had 
been approved by the Hospital Review Board. Patients over the 
age of  16 years were included, including those with fractures 
secondary to tumors or with localized bone pathology—such 
as Paget’s disease. 
Preoperative  data  included  the  patient  demographics, 
patient’s residence preoperatively, mobility (including the use 
of walking aids), mental test score, and smoking status. In 
addition, the hemoglobin (g/L) on admission was recorded. 
The length of time from fracture to admission and from frac-
ture to surgery was also documented. 
Mobility was assessed using a mobility score rated from 0 
to 9. A score of 9 represented full mobility without the use of 
walking aids, while a score of 0 signified that the patient was 
bed-bound (Parker and Palmer 1993). The mental test score 
was a series of 10 questions on recall, scored from 0 to 10 
(Qureshi and Hodkinson 1974). 
Operative details regarding the type of procedure performed, 
the length of surgery, and length of anesthesia were collected. 
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any analysis involving operative timing. The type of anes-
thetic was documented, as was any co-morbidity (as assessed 
by ASA grade). 
Fractures  were  classified  into  intracapsular,  inter-tro-
chanteric, and sub-trochanteric (Parker 2001). Intracapsular 
hip fractures were treated either with fixation with multiple 
screws  or  with  a  hemiarthroplasty.  Extracapsular  fractures 
were treated by internal fixation with a sliding hip screw or an 
intramedullary nail.
All symptomatic VTE cases were recorded, defined as any 
case  of  symptomatic  deep  vein  thrombosis  or  pulmonary 
embolism. Deep vein thrombosis was defined as any thrombo-
sis diagnosed by ultrasound, venography, or at autopsy. Pul-
monary embolism was diagnosed by computer tomography 
pulmonary  angiography  (CTPA),  nuclear  medicine  isotope 
scanning, or at autopsy. All patients presenting with symptoms 
of VTE were subject to investigation. 
After discharge from hospital, at least 1 follow-up assessment 
was undertaken in a hip-fracture clinic after 6 weeks. Subse-
quent follow-up was by telephone with a final follow-up at 1 
year after admission. Any patient who had been diagnosed with 
a VTE in the community was identified at the follow-up points.
All patients received thromboprophylaxis, which was given 
from the day of admission. From 1989 until 1992, unfraction-
ated calcium heparin was used (5,000 units twice daily). In 
1992, the thromboprophylaxis regime was changed to low-
molecular-weight heparin (Enoxaparin, 40 mg once a day). 
The thromboprophylaxis regime was continued for 14 days 
after surgery. Graduated compression stockings and mechani-
cal calf or foot pumps were not used. After surgery, all patients 
were mobilized as soon as possible.
Statistics
Initially, the baseline characteristics of the group that presented 
with VTE were compared with the baseline characteristics of 
the group without VTE. The methods of analysis were chi-
squared test for categorical variables, the Mann-Whitney test 
for variables involving length of time, and t-test for other con-
tinuous variables. Statistically significant risk factors for VTE 
were assessed together by multivariate analysis in a logistic 
regression model, adjusting for sex and age. Effects are pre-
sented as odds ratios, which approximate to relative risk due 
to the low incidence rates.
The VTE group was subdivided into the subcategories of 
deep  vein  thrombosis  and  pulmonary  embolism,  and  com-
pared with the group with no thrombosis using similar meth-
ods. All tests were two-sided, and were assessed both at the 
5% level of significance—and also at the stricter 1% level. 
Analyses were done using SPSS version 12.0.1.
Results
Between January 1989 and January 2007, 5,300 patients were 
admitted to our institution with a proximal femoral fracture.   
86 patients were treated non-operatively, and they were there-
fore excluded from any analysis involving operative timing. 
The average age of the patients was 80 (17–103) years and 
78% were female. There were 117 venous thromboembolic 
complications (2.2%, 95% CI: 1.8–2.6). 79 patients (1.5%) 
were  diagnosed  with  only  a  deep  vein  thrombosis  and  38 
(0.7%) presented with a pulmonary embolus (Table 1). There 
was a higher incidence of deep venous thrombosis in those 
patients who had a sliding hip-screw fixation and intramedul-
lary nail (p = 0.01) (Table 2).
 The logistic regression analysis, adjusting for age and sex, 
showed that those patients who had lived in their own home 
and who had presented with an inter-trochanteric or sub-tro-
chanteric fracture or with elevated hemoglobin at admission 
were at higher risk of developing a VTE. (Table 3) Other fac-
tors that were significant in univariate but not in multivariate 
analysis were: better preoperative mobility (p = 0.01), high 
mental test score (p = 0.005), and fixation with a dynamic hip 
screw (p = 0.03). 
The mean time to presentation and diagnosis of the VTE 
was 24 (3–91) days, with patients presenting up to 13 weeks 
after injury. (Figure 1) The mean time to presentation of deep 
vein thrombosis was 25 (4–91) days and the mean time to pre-
sentation of pulmonary embolism was 20 (3–81) days. 85% of 
these events occurred within 5 weeks of the fracture.
Discussion
In this study of 5,300 hip fracture patients who received hepa-
rin thromboprophylaxis, we found an incidence of symptom-
atic VTE of 2.2%. This rate is in keeping with other reports, 
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Figure 1. Time from fracture to diagnosis of thrombo-
embolic complications.Acta Orthopaedica 2009; 80 (6): 687–692  689
such, would report a higher incidence 
of VTE. Thus, rates of VTE of up to 
42% for patients with proximal femo-
ral fractures have been reported (Han-
doll et al. 2002). 
While  patients  with  hip  fractures 
are identified as belonging to a high 
risk group for development of throm-
boembolism (Geerts et al. 2004), it is 
difficult  to  predict  which  individual 
patients  in  a  given  risk  group  will 
develop a clinically important throm-
boembolic event. Our study suggests 
that  patients  with  either  inter-tro-
chanteric  or  sub-trochanteric  frac-
tures, those living in their own home, 
and those admitted with an elevated 
hemoglobin value are at higher risk of 
development of symptomatic VTE. 
Other authors have been unable to 
identify a difference in the incidence 
of  thromboembolic  complications 
between those patients with intracap-
sular fractures and those with extra-
capsular fractures (Hefley et al. 1996). 
We  suggest  that  one  reason  for  the 
difference in the rate of VTE between 
extracapsular and intracapsular frac-
tures may be the more extensive blood 
loss within the tissues, and the resul-
tant swelling of the limb that occurs 
with an extracapsular fracture. 
Regarding  the  other  risk  factors, 
the reasons are not entirely clear. For 
those patients who are more mobile 
and  living  in  their  own  home,  it  is 
possible that the lower mortality rate 
in this group of patients may be part 
of the explanation for the higher inci-
dence of VTE; and it is also possible 
that these patients are more likely to 
report symptoms suggestive of throm-
bosis (Parker 2001). 
We  were  not  able  to  demonstrate 
any  increase  in  the  occurrence  of 
VTE related to the delay of surgery 
(p = 0.8). This lack of any association 
has also been found in previous stud-
ies (Bredahl et al. 1992, Davis et al. 
1998, Grimes et al. 2002, Moran et al. 
Table 1. Characteristics of the patients on admission related to the occurrence of thrombo-
embolic complications (percentage with and without a thrombotic episode and its subcat-
egories within the category of each characteristic) 
  No thrombosis   Any thrombosis   Deep vein    Pulmonary 
      thrombosis  embolism
Total numbers   5,183   117   79   38
Sex 
  Female    4,062 (98%)   97 (2.3%)   66 (1.6%)   31 (0.8%)
  Male   1,121 (98%)   20 (1.8%)   13 (1.1%)     7 (0.6%)
  p-value      0.3  0.3   0.7
Mean age (SD)    80 (11)   79 (12)   79 (11)   80 (9.9)
  p-value      0.7   0.7   1
Admission mobility score
(n = 5298) b
    8–9   1,466 (97%)   47 (3.1%)   34 (2.3%)   13 (0.9%)
  4–7   1,834 (98%)   38 (2.0%)   27 (1.5%)   11 (0.6%)  
  0–3   1,881 (98%)   32 (1.7%)   18 (1.0%)   14 (0.7%) 
  p-value       0.01   0.008   0.6
Use of walking aids
(n = 5293) 
  None   2,833 (98%)   74 (2.5%)   52 (1.8%)   22 (0.8%) 
  Aids   2,230 (98%)   42 (1.8%)   27 (1.2%)   15 (0.7%) 
  Immobile      114 (100%)     0 (0%)     0 (0%)     0 (0%) 
  p-value      0.06   0.08  0.6
Residence on admission
(n = 5300) b 
  Own home   3,715 (97%)   99 (2.6%)   67 (1.8%)   32 (0.8%) 
  Institution   1,468 (99%)   18 (1.2%)   12 (0.8%)     6 (0.4%) 
  p-value      0.002   0.008   0.4
ASA grade 
  1–2   1,750 (98%)   35 (2.0%)   24 (1.4%)     9 (0.5%) 
  3–5   3,331 (98%)   80 (2.3%)   54 (1.6%)   21 (0.6%) 
  p-value       0.4   0.6   0.7
Mental test score
(n = 4849) b
   0–5   1,494 (99%)   19 (1.3%)   11 (0.7%)     8 (0.5%) 
  6–10   3,255 (98%)   85 (2.5%)   60 (1.8%)   25 (0.7%) 
  p-value      0.005   0.004   0.5
Smoking status
(n = 4985) 
  Non-smoker   4,267 (98%)   92 (2.1%)   62 (1.4%)   30 (0.7%) 
  Smoker      611 (98%)   15 (2.4%)   13 (2.1%)     2 (0.3%) 
  p-value       0.7   0.2   0.4
Mean hemoglobin on 
admission (g/L)
(n = 5232) a   124    128   127   129 
  p-value      0.03   0.2   0.06
Type of fracture
(n = 5300) b
  Intracapsular   2,917 (98%)   50 (1.7%)   30 (1.0%)   20 (0.7%) 
  Intertrochanteric   2,032 (97%)   63 (3.0%)   46 (2.2%)   17 (0.8%) 
  Subtrochanteric      180 (98%)     4 (2.2%)     3 (1.7%)     1 (0.6%) 
  p-value       0.008   0.002   0.8
Pathological fracture
(n = 5046) 
  No   4,916 (98%)   115 (2.3%)   77 (1.6%)   30 (0.6%) 
  Yes        22 (96%)       1 (4.3%)     1 (4.3%)     0 (0%) 
  p-value      1   0.3   1
a Risk factor for any thrombosis significant at the 5% level.
b Risk factor for any thrombosis significant at the 1% level.
and  6%  have  been  reported  (Todd  et  al.  1995,  PEP  2000, 
Eriksson and Lasssen 2003, Rosencher et al. 2006). By com-
parison, most studies of VTE and its prevention have used sen-
sitive diagnostic tests to detect deep vein thrombosis and, as 
2005). However, other studies have reported an association 
between surgical delay and an increased risk of VTE (Hefley 
et al. 1996, Zahn et al. 1999, Elder et al. 2005). 
The univariate analysis demonstrated a statistically signifi-690  Acta Orthopaedica 2009; 80 (6): 687–692
groups appear to be at a higher risk of developing a VTE. In 
these groups of patients, it may be appropriate to consider 
extended thromboprophylaxis.
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cantly higher number of PEs diagnosed in patients who had 
undergone surgery using a general anesthetic. Such signifi-
cance was not apparent in the total number of VTE patients 
or in the subcategory of patients with deep vein thrombosis. 
While previous studies have indicated that the incidence of 
VTE may be reduced with spinal anesthesia (Parker et al. 
2004),  possibly  due  to  an  increased  peripheral  blood  flow 
induced by spinal anesthesia, we were unable to demonstrate 
any statistically significant reduction in the occurrence of VTE 
for patients in our series. 
We are aware of the weaknesses of 
our study. We had to use the ASA grade 
as a marker of co-morbidity at the time 
of operation. We found it impossible to 
analyze  independent  co-morbidities, 
such as heart failure, as the recording 
of  past  medical  histories  was  often 
unreliable. However, we did find it sur-
prising  that  there  was  no  statistically 
significant increase in the incidence of 
VTE in those patients with higher ASA 
grades  or  in  those  with  pathological 
fractures. In addition, it was not possi-
ble to analyze the data before and after 
the change in heparin regimes. How-
ever, a previous Cochrane review came 
to the conclusion that there was insuffi-
cient evidence to differentiate between 
the  effectiveness  of  different  heparin 
preparations (Handoll et al. 2002). 
In summary, we found that the occur-
rence of clinically detected thrombosis 
after hip fracture was low in patients 
who  are  given  low-dose  subcutane-
ous  heparin  from  admission.  Despite 
thromboprophylaxis,  various  patient 
Table 2. Operation factors related to the occurrence of thromboembolic complications (per-
centage with and without a thrombotic episode and its subcategories within the category 
of each factor)
  No thrombosis   Any thrombosis   Deep vein    Pulmonary 
      thrombosis  embolism
Median time from fracture
to surgery (h)    25   25    25    22.5  
  p-value      0.8   1   0.2
Median time from 
admission to surgery (h)    21   22    22    20  
  p-value      0.47   0.38   0.99
Type of anesthetic 
  General   2,933 (98%)   75 (2.5%)   47 (1.6%)   29 (1.0%) 
  Spinal    1,837 (98%)   38 (2.0%)   29 (1.6%)     9 (0.5%) 
  Local       282 (99%)     2 (0.7%)     2 (0.7%)     0 
  p-value      0.12   0.53   0.05
Median length of 
anesthesia (min) a  60  60    60    60  
  p-value      0.05   0.09   0.3
Type of operation b
  Hemiarthroplasty   1,645 (98%)   28 (1.7%)   19 (1.1%)     9 (0.5%) 
  Sliding hip screw   1,863 (97%)   56 (2.9%)   40 (2.1%)   16 (0.8%) 
  Intramedullary nail      327 (97%)   11 (3.3%)     9 (2.7%)     2 (0.6%) 
  Multiple screws   1,262 (98%)   21 (1.6%)   11 (0.9%)   10 (0.8%) 
  Conservative        86 (99%)     1 (1.1%)     0 (0%)     1 (1.1%) 
  p-value       0.03   0.01   0.8
a Risk factor for any thrombosis significant at the 5% level.
b Risk factor for any thrombosis significant at the 1% level.
Table 3. Logistic regression adjusting for age and sex (incidence odds ratios of thrombosis for fac-
tors significant in multivariate analysis)
  No thrombosis   Any thrombosis   Odds ratio (95% CI)   p-value
Sex 
  Female   4,062 (98%)   97 (2.3%)   1    0.09 
  Male   1,121 (98%)   20 (1.8%)   0.64  (0.38–1.07)
Mean age  (SD)  80 (11)   79 (12)   1.0  (0.98–1.02)   0.9
Residence on admission  
  Own home   3,715 (97%)   99 (2.6%)   2.24  (1.32–3.82)   0.003 
  Institution   1,468 (99%)   18 (1.2%)   1
Mean hemoglobin
on admission (SD)    124 (17)   128 (18)   1.01  (1.0–1.03)   0.01
Type of fracture  
  Intracapsular   2,917 (98%)   50 (1.7%)   1    0.001 
  Intertrochanteric   2,032 (97%)   63 (3.0%)   2.15  (1.46–3.17) 
  Subtrochanteric      180 (98%)     4 (2.2%)   1.51  (0.53–4.30)Acta Orthopaedica 2009; 80 (6): 687–692  691
Bredahl C, Nyholm B, Hindsholm K B, Mortensen J S, Olesen A S. Mortal-
ity after hip fracture: results of operation within 12 h of admission. Injury 
1992; 23: 83-6. 
Davis T R, Sher J L, Porter B B, Checketts R G. The timing of surgery for 
intertrochanteric femoral fractures. Injury 1988; 19: 244-6.
Elder G M, Harvey E J, Vaidya R, Guy P, Meek R N, Aebi M. The effective-
ness of orthopaedic trauma theatres in decreasing morbidity and mortality: 
a study of 701 displaced subcapital hip fractures in two trauma centres. 
Injury 2005; 36: 1060-6. 
Eriksson B J, Lassen M R. Duration of prophylaxis against venous throm-
boembolism with fondaparinux after hip fracture surgery: a multicentre, 
randomized placebo-controlled, double-blind study. Arch Int Med 2003; 
163; 1337-42.
Geerts W H, Pineo G F, Heit J A, Bergqvist D, Lassen M R, Colwell C W, Ray 
J G. Prevention of venous thromboembolism: the Seventh ACCP Confer-
ence on Antithrombotic and Thrombolytic Therapy. Chest (3 Suppl) 2004; 
126: 338S-400S.  
Grimes J P, Gregory P M, Noveck H, Butler M S, Carson J L. The effects of 
time-to-surgery on mortality and morbidity in patients following hip frac-
ture. Am J Med 2002; 112: 702-9. 
Haake D A, Berkman S A. Venous thromboembolic disease after hip surgery. 
Risk factors, prophylaxis and diagnosis. Clin Orthop 1989; (242): 212-31.
Handoll H H G, Farrar M J, McBirnie J, Tytherleigh-Strong G, Milne A A, 
Gillespie W J. Heparin, low molecular weight heparin and physical meth-
ods for preventing deep vein thrombosis and pulmonary embolism follow-
ing surgery for hip fractures. Cochrane Database of Systematic Reviews 
2002, Issue 2. Art. No.: CD000305. DOI: 10.1002/14651858.CD000305 
(Accessed 12/8/08)
Hefley F G Jr, Nelson C L, Puskarich-May C L. Effect of delayed admis-
sion to the hospital on the preoperative prevalence of deep-vein thrombosis 
associated with fractures about the hip. J Bone Joint Surg (Am) 1996; 78: 
581-3.
Moran C G, Wenn R T, Sikand M, Taylor A M. Early mortality after hip frac-
ture: is delay before surgery important? J Bone Joint Surg (Am) 2005; 87: 
483-9.
Parker M J. Trochanteric and subtrochanteric fractures. Oxford Textbook of 
Orthopaedics and Trauma. Oxford University Press, Oxford 2001.
Parker M J, Palmer C R. A new mobility score for predicting mortality after 
hip fracture. J Bone Joint surg (Br) 1993; 75: 797-8
Parker M J, Handoll H H G, Griffiths R. Anaesthesia for hip fracture sur-
gery in adults. Cochrane Database of Systematic Reviews 2004, Issue 2. 
Art. No.: CD000521. DOI: 10.1002/14651858.CD000521.pub2 (Accessed 
12/8/08)
Pulmonary Embolism Trial Collaborative Group. Prevention of pulmonary 
embolism and deep vein thrombosis with low dose aspirin. Pulmonary 
Embolism Prevention (PEP) Trial. Lancet 2000; 355: 1295-303. 
Qureshi K N, Hodkinson H M. Evaluation of a ten-question mental test in the 
institutionalised elderly. Age Ageing 1974; 3: 152–7.
Rosencher N, Vielpeau C, Emmerich J, Fagnani F, Samama C M. Venous 
thromboembolism and mortality after hip fracture: the ESCORTE study. J 
Thromb Haemostasis 2006; 3: 2006-14.
Todd C J, Freeman C J, Camilleri-Ferrante C, Palmer C R, Hyder A, Laxton 
C E, Parker M J, Payne B V, Rushton N. Differences in mortality after frac-
ture of the hip: the East Anglian audit. Br Med J 1995; 310: 904-8.
Zahn H R, Skinner J A, Porteous M J. The preoperative prevalence of deep 
vein thrombosis in patients with femoral neck fractures and delayed opera-
tion. Injury 1999; 30: 605-7.